drugset / Trial / NCT04163783
Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-BGB-3111 in Healthy Males
NaSingle-groupOpen-labelBasic science
Summary
Phase 1 study in healthy subjects to determine the effect of an 8-hour fast from food on the pharmacokinetics of \[14C\]-BGB-3111.
Timeline
- Start
- 2017-03-29
- Primary completion
- 2017-04-18
- Completion
- 2017-04-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zanubrutinib | Small molecule | 320 mg | Oral |
Indications
No indication recorded.